Article
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
The Lancet. Oncology - 1 Sept 2011
Castle Philip E, Stoler Mark H, Wright Thomas C, Sharma Abha, Wright Teresa L, Behrens Catherine M
Abstract excerpt
BACKGROUND: The ATHENA study was designed to assess the performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping compared with liquid-based cytology for cervical cancer screening in a large US population aged 21 years and older. We did a subanalysis of this population to compare the screening performance of the cobas HPV test versus liquid-based cytology in women aged 25 years...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.